[go: up one dir, main page]

YU9003A - Pharmaceutical composition containing citalopram - Google Patents

Pharmaceutical composition containing citalopram

Info

Publication number
YU9003A
YU9003A YU9003A YUP9003A YU9003A YU 9003 A YU9003 A YU 9003A YU 9003 A YU9003 A YU 9003A YU P9003 A YUP9003 A YU P9003A YU 9003 A YU9003 A YU 9003A
Authority
YU
Yugoslavia
Prior art keywords
citalopram
pharmaceutical composition
composition containing
containing citalopram
mixture
Prior art date
Application number
YU9003A
Other languages
Serbo-Croatian (sh)
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Sven Wagner
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU9003(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of YU9003A publication Critical patent/YU9003A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A solid unit dosage form comprising citalopram, which is prepared by direct compression of a mixture of citalopram base or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable excipients, or by filling of said mixture in a hard gelatine capsule. Large crystals of a pharmaceutical acceptable salt of citalopram and method for the manufacture of said large crystals.
YU9003A 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram YU9003A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (1)

Publication Number Publication Date
YU9003A true YU9003A (en) 2006-05-25

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
YU9003A YU9003A (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (en)
JP (1) JP2003531153A (en)
KR (1) KR20030024833A (en)
CN (1) CN1446089A (en)
AR (1) AR030095A1 (en)
AT (1) AT5744U1 (en)
AU (2) AU2001100198B4 (en)
BE (1) BE1013559A6 (en)
BG (1) BG107578A (en)
BR (1) BR0113250A (en)
CA (1) CA2353693C (en)
CH (2) CH694241A5 (en)
CZ (1) CZ2003397A3 (en)
DE (2) DE10139115A1 (en)
EA (1) EA200300247A1 (en)
ES (1) ES2172481B2 (en)
FI (1) FI5176U1 (en)
FR (1) FR2812811B1 (en)
GB (1) GB2368014B (en)
GR (1) GR1004193B (en)
HR (1) HRP20030054A2 (en)
HU (1) HUP0103071A3 (en)
IE (1) IES20010693A2 (en)
IL (1) IL154050A0 (en)
IS (1) IS6021A (en)
IT (1) ITMI20011637A1 (en)
MX (1) MXPA03000837A (en)
NL (1) NL1018741C1 (en)
NO (1) NO20013891L (en)
NZ (1) NZ523785A (en)
PL (1) PL359824A1 (en)
SK (1) SK2842003A3 (en)
WO (1) WO2001080619A2 (en)
YU (1) YU9003A (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
BR0317623A (en) * 2002-12-23 2005-11-29 Lundbeck & Co As H Escitalopram, pharmaceutical composition, and use of escitalopram hydrobromide
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (en) * 2006-01-05 2007-12-12 昆明积大制药有限公司 Antidepressant composition containing citalopram and cyclodextrin
GB2446847B (en) * 2007-02-02 2012-02-22 Ubiquisys Ltd Location of Basestation
CN106397248A (en) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 LCZ696 crystallized powder and a preparing method thereof
EP4277661A1 (en) * 2021-01-18 2023-11-22 Anton Frenkel Pharmaceutical dosage form
EP4661849A1 (en) 2023-02-07 2025-12-17 Kinast, Lasse An immediate-release oral pharmaceutical form of escitalopram or racemate thereof with increased api content

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of a drug by a serotonin 1A receptor antagonist
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
KR20030024833A (en) 2003-03-26
IL154050A0 (en) 2003-07-31
AR030095A1 (en) 2003-08-13
CH694241A5 (en) 2004-10-15
BE1013559A6 (en) 2002-03-05
NZ523785A (en) 2004-09-24
HRP20030054A2 (en) 2005-02-28
JP2003531153A (en) 2003-10-21
EP1318805A2 (en) 2003-06-18
GR1004193B (en) 2003-03-24
NL1018741C1 (en) 2002-02-12
ITMI20011637A0 (en) 2001-07-27
DE10139115A1 (en) 2002-03-28
HUP0103071A3 (en) 2002-12-28
HUP0103071A2 (en) 2002-05-29
CH694242A5 (en) 2004-10-15
DE20113195U1 (en) 2001-11-15
ITMI20011637A1 (en) 2003-01-27
GB2368014A (en) 2002-04-24
ES2172481B2 (en) 2004-08-01
WO2001080619A3 (en) 2002-02-21
GB2368014B (en) 2004-06-23
IES20010693A2 (en) 2002-07-10
GR20010100377A (en) 2002-09-06
BR0113250A (en) 2003-06-24
CA2353693C (en) 2003-07-22
AU2001279591A1 (en) 2001-11-07
IS6021A (en) 2001-10-20
SK2842003A3 (en) 2003-09-11
CA2353693A1 (en) 2002-01-22
AT5744U1 (en) 2002-11-25
AU2001100198A4 (en) 2001-08-16
NO20013891L (en) 2002-02-11
FI5176U1 (en) 2001-12-27
CZ2003397A3 (en) 2003-06-18
ES2172481A1 (en) 2002-09-16
GB0118579D0 (en) 2001-09-19
PL359824A1 (en) 2004-09-06
EA200300247A1 (en) 2003-06-26
NO20013891D0 (en) 2001-08-09
AU2001100198B4 (en) 2002-06-13
FR2812811A1 (en) 2002-02-15
CN1446089A (en) 2003-10-01
BG107578A (en) 2003-09-30
FR2812811B1 (en) 2006-08-18
HU0103071D0 (en) 2001-10-28
MXPA03000837A (en) 2003-06-06
WO2001080619A2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
ES2172481A1 (en) Pharmaceutical composition containing citalopram
DE69620606D1 (en) FIXED ORAL APPLICATION FORM
DK1117383T3 (en) Dosage forms comprising therapeutic formulation
RU2003116058A (en) COMPOSITIONS OF A HYDROCODON WITH CONTROLLED RELEASE
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
EP1246622A4 (en) NEW DOSAGE FORMS OF BENZIMIDAZOLE SUBSTITUTE
YU21999A (en) Pharmaceutical compositions and procedure for the production thereof
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
AP2003002763A0 (en) Controlled release formulations for oral administration
RU2003100507A (en) PHARMACEUTICAL COMPOSITIONS
MXPA03011317A (en) Swallow tablet comprising paracetamol.
SE8901003D0 (en) QUICKLY PREPARATION
HUP0203148A2 (en) Orally distintegrating composition comprising mirtazapine
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
TW200517127A (en) Novel composition
YU54503A (en) Pharmaceutical composition containing citalopram
GEP20043377B (en) Pharmaceutical Complex
TNSN06003A1 (en) Saquinavir mesylate oral dosage form
SI1530459T1 (en) Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
TW200500085A (en) Sustained-release pharmaceutical composition for lung administration
MY131159A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
RU2002126216A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF LIVER FIBROSIS AND CIRROSIS
MY145885A (en) Controlled release formulations for oral administration
PE20030546A1 (en) A RIGID CAPSULES TYPE PHARMACEUTICAL DOSE UNIT FORM CONTAINING LYSINE CLONIXINATE, A PROCEDURE FOR ITS PREPARATION AND THE USE OF SAID DOSE UNIT AS ANALGESIC AND / OR ANTI-INFLAMMATORY
PL355467A1 (en) Pharmaceutical composition for filling hard gelatine capsules, method of producing pharmaceutical composition for filling hard gelatine capsules and hard the hard gelatine capsules